Cantargia to Participate at Van Lanschot Kempen's Life Sciences Conference
Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA) today announced that members of Cantargias management will participate in one-on-one meetings at the Van Lanschot Kempen Life Sciences Conference in Amsterdam on Thursday, April 16, 2026.For further information, please contactHilde Steineger, CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected] CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company...
Read more








